- Home
- REFI vs QSI Comparison
REFI vs QSI Comparison
Compare REFI & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- QSI
- Stock Information
- Founded
- REFI 2021
- QSI 2013
- Country
- REFI United States
- QSI United States
- Employees
- REFI N/A
- QSI N/A
- Industry
- REFI Real Estate Investment Trusts
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- REFI Real Estate
- QSI Health Care
- Exchange
- REFI Nasdaq
- QSI Nasdaq
- Market Cap
- REFI 274.3M
- QSI 226.8M
- IPO Year
- REFI 2021
- QSI N/A
- Fundamental
- Price
- REFI $13.37
- QSI $1.26
- Analyst Decision
- REFI Strong Buy
- QSI Strong Buy
- Analyst Count
- REFI 3
- QSI 3
- Target Price
- REFI $20.00
- QSI $2.38
- AVG Volume (30 Days)
- REFI 130.8K
- QSI 5.5M
- Earning Date
- REFI 11-06-2025
- QSI 11-11-2025
- Dividend Yield
- REFI 15.44%
- QSI N/A
- EPS Growth
- REFI N/A
- QSI N/A
- EPS
- REFI 1.84
- QSI N/A
- Revenue
- REFI $56,608,781.00
- QSI $3,412,000.00
- Revenue This Year
- REFI $9.93
- QSI $45.62
- Revenue Next Year
- REFI $4.99
- QSI $218.03
- P/E Ratio
- REFI $7.26
- QSI N/A
- Revenue Growth
- REFI 2.58
- QSI 100.47
- 52 Week Low
- REFI $12.76
- QSI $0.61
- 52 Week High
- REFI $16.29
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- REFI 39.83
- QSI 54.46
- Support Level
- REFI $13.08
- QSI $0.95
- Resistance Level
- REFI $14.57
- QSI $1.16
- Average True Range (ATR)
- REFI 0.32
- QSI 0.08
- MACD
- REFI -0.12
- QSI 0.04
- Stochastic Oscillator
- REFI 19.46
- QSI 88.46
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.